Kaloba (Pelargonium Sidoides Root Liquid Extraction Preparation (1 : 8-10), Extraction Solvent: Ethanol 11 %)

The extract is believed to stimulate the body's innate immune response by activating macrophages and increasing cytokine production. It also enhances ciliary movement in the airways, helping to clear mucus and reduce inflammation, which together contribute to symptom improvement.

The appropriate dose of Kaloba is determined by the prescribing clinician based on the patient’s age, weight, and clinical condition. Dosage instructions are provided on the product label and should be followed exactly as directed by a healthcare professional.

Safety data for Kaloba in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using the product.

To place an order, submit an enquiry on the Kaloba product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kaloba’s primary active ingredient, Pelargonium sidoides, is distinguished by its documented immunomodulatory and mucokinetic properties. Compared with generic cough syrups that contain only demulcents, Kaloba offers a mechanism that actively supports pathogen clearance, though clinical outcomes may vary among individuals.

Kaloba should be stored at ambient temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and store it in its original packaging to maintain product stability.

Kaloba is taken orally as a liquid. The prescribed dose is measured with the supplied dropper or measuring device and swallowed directly. It can be taken with or without food, according to the prescriber’s guidance.

Serious adverse reactions, although rare, include anaphylaxis, severe skin reactions such as angioedema, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, swelling of the face or throat, or persistent jaundice.

Kaloba should be avoided by individuals with a known hypersensitivity to Pelargonium species or any of the formulation excipients. It is also contraindicated in patients with severe liver impairment or those who have experienced serious allergic reactions to similar herbal products.